406 related articles for article (PubMed ID: 17553070)
21. The pharmaceutical pipeline for atrial fibrillation.
Santangeli P; Di Biase L; Pelargonio G; Burkhardt JD; Natale A
Ann Med; 2011 Feb; 43(1):13-32. PubMed ID: 21166558
[TBL] [Abstract][Full Text] [Related]
22. Lipid-altering therapy and atrial fibrillation.
Bachmann JM; Majmudar M; Tompkins C; Blumenthal RS; Marine JE
Cardiol Rev; 2008; 16(4):197-204. PubMed ID: 18562810
[TBL] [Abstract][Full Text] [Related]
23. Outpatient use of anticoagulants, rate-controlling drugs, and antiarrhythmic drugs for atrial fibrillation.
Allen LaPointe NM; Governale L; Watkins J; Mulgund J; Anstrom KJ
Am Heart J; 2007 Nov; 154(5):893-8. PubMed ID: 17967595
[TBL] [Abstract][Full Text] [Related]
24. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
Makkar KM; Sanoski CA; Spinler SA
Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
[TBL] [Abstract][Full Text] [Related]
25. [Pharmacological treatment of atrial fibrillation].
Davy JM; Razcka F; Beck L; Cung TT; Combes N
Arch Mal Coeur Vaiss; 2004 Dec; 97 Spec No 4(4):63-70. PubMed ID: 15714891
[TBL] [Abstract][Full Text] [Related]
26. [Drug treatment of atrial fibrillation].
Janko S; Hoffmann E
MMW Fortschr Med; 2006 Apr; 148(15):32-5. PubMed ID: 16711199
[TBL] [Abstract][Full Text] [Related]
27. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: who is a responder?
Berkowitsch A; Neumann T; Kuniss M; Janin S; Wojcik M; Zaltsberg S; Mitrovic V; Pitschner HF
Pacing Clin Electrophysiol; 2010 Sep; 33(9):1101-11. PubMed ID: 20487340
[TBL] [Abstract][Full Text] [Related]
28. [The use of other drugs apart from antithrombotic and antiplatelet agents for the treatment of non-ST-elevation acute coronary syndromes].
Birdane A; Ata N
Anadolu Kardiyol Derg; 2006 Apr; 6 Suppl 1():30-4. PubMed ID: 16613773
[TBL] [Abstract][Full Text] [Related]
29. [Non-antiarrhythmic drug therapy for the prevention of atrial fibrillation?].
Fauchier L; Zannad N; Clementy N; Pierre B; Cosnay P; Babuty D
Ann Cardiol Angeiol (Paris); 2010 Dec; 59 Suppl 1():S28-32. PubMed ID: 21211623
[TBL] [Abstract][Full Text] [Related]
30. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
[TBL] [Abstract][Full Text] [Related]
31. [Non-antiarrhythmic pharmacological treatment of atrial fibrillation: focus on drugs acting on the renin-angiotensin system].
Durin O; Pedrinazzi C; Inama G
G Ital Cardiol (Rome); 2008 Oct; 9(10 Suppl 1):5S-10S. PubMed ID: 19195299
[TBL] [Abstract][Full Text] [Related]
32. [New strategies in the treatment of atrial fibrillation].
Tamargo Menéndez J
An R Acad Nac Med (Madr); 2007; 124(2):305-16; discussion 316-8. PubMed ID: 18069598
[TBL] [Abstract][Full Text] [Related]
33. [Medical treatment of small abdominal aortic aneurysms].
Høgh AL; Sandermann J; Lindholt JS
Ugeskr Laeger; 2008 Jun; 170(23):2003-5. PubMed ID: 18534161
[TBL] [Abstract][Full Text] [Related]
34. [Pathophysiology of the renin-angiotensin-system in atrial fibrillation].
Heusch G; Schulz R
Dtsch Med Wochenschr; 2006 Apr; 131(15):817-20. PubMed ID: 16607602
[TBL] [Abstract][Full Text] [Related]
35. Cardiovascular drug therapy in the elderly.
Aronow WS; Frishman WH; Cheng-Lai A
Cardiol Rev; 2007; 15(4):195-215. PubMed ID: 17575484
[TBL] [Abstract][Full Text] [Related]
36. [Unsatisfactory results of upstream therapy with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for the prevention of recurrent atrial fibrillation].
Disertori M; Zeni P; Quintarelli S; Bonmassari R
G Ital Cardiol (Rome); 2010 Nov; 11(11):829-34. PubMed ID: 21348320
[TBL] [Abstract][Full Text] [Related]
37. Is atrial fibrillation an inflammatory disorder?
Boos CJ; Anderson RA; Lip GY
Eur Heart J; 2006 Jan; 27(2):136-49. PubMed ID: 16278230
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein (CRP)-lowering agents.
Prasad K
Cardiovasc Drug Rev; 2006; 24(1):33-50. PubMed ID: 16939632
[TBL] [Abstract][Full Text] [Related]
39. Statins and polyunsaturated fatty acids for treatment of atrial fibrillation.
Savelieva I; Camm J
Nat Clin Pract Cardiovasc Med; 2008 Jan; 5(1):30-41. PubMed ID: 18094671
[TBL] [Abstract][Full Text] [Related]
40. [Atrial fibrillation and renin-angiotensin system].
Yamashita T
Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
